Celebrating 200,000 treatments

21 September 2022
/ News

Emblation has reached a milestone after completing 200,000 treatments with our innovative microwave device for treating common skin problems.

Health tech innovator sitting pretty with move into skin clinic

9 August 2022
/ News

Our exciting skin treatment device has made its first crossover breakthrough into an aesthetic clinic, after taking the podiatry world by storm.

IDE Approval Received from the FDA for the SWIFT multi-centre, open, randomized, controlled, parallel-group, blind-assessed trial

6 June 2022
/ News

IDE approval was received in April 2022 from the FDA for the SWIFT multi-centre, open, randomized, controlled, parallel-group, blind-assessed trial.

Scottish health tech innovator hits 100,000 treatments in UK

31 May 2022
/ News

The Emblation team are proud to have launched in Europe’s biggest healthcare market, after striking a partnership deal with a leading German medical device company.

German deal is milestone for Scots microwave health pioneer

27 April 2022
/ News

The Emblation team are proud to have launched in Europe’s biggest healthcare market, after striking a partnership deal with a leading German medical device company.

Microwave health tech firm uses war chest to conquer Europe

30 March 2022
/ News

Our burgeoning health tech firm is tapping into an eight-figure investment war chest to deliver rapid European growth.

Emblation shortlisted for two Ceed Annual Industry Awards

22 February 2022
/ News

Emblation is delighted to announce we have been shortlisted for two Ceed awards, Innovation and Internationalisation.